《盈警響號》中核國際(02302.HK)料去年虧損降至最少5,000萬元
中核國際(02302.HK)公布,預期集團截至去年12月31日止年度的收入及毛利按年將大幅減少,減幅分別不少於港幣15億元和800萬元,主要來自供應鏈管理業務,並將錄得淨虧損減少至不少於5,000萬元(2019年淨虧損約2.19億元)。
淨虧損減少主要是由於預期存貨減值虧損約5,200萬元,而2019年集團蒙古礦業項目的減值虧損則約為2.1億元;及於去年應佔一間聯營公司之溢利約1,400萬元,而2019年應佔聯營公司之虧損則約200萬元。集團早前公布對剩餘的主要包括電子元件的存貨進行進一步測試發現,由於存貨缺陷,此類存貨可能僅具有微不足道的可變現淨值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.